Immediate Impact

50 standout
Sub-graph 1 of 18

Citing Papers

AXL signaling in cancer: from molecular insights to targeted therapies
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
1 intermediate paper

Works of Lih‐Yu Chang being referenced

Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors
2019

Author Peers

Author Last Decade Papers Cites
Lih‐Yu Chang 154 135 143 29 447
Jorge Lascano 178 51 114 42 448
Inge A. H. van den Berk 203 93 78 23 416
Yanling Ding 114 79 83 31 460
Simone Cristina Soares Brandão 151 76 42 53 470
Sheng‐Kai Liang 170 52 64 31 479
Charalampos Gogos 60 65 216 25 460
Fumio Hirose 82 66 59 39 444
Goeun Park 57 48 132 47 456
Sei Won Kim 186 112 94 41 492
Jihong Zhu 48 99 98 46 376

All Works

Loading papers...

Rankless by CCL
2026